740 POSTER Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy in patients with advanced gastric cancer —interim analysis of a multicenter, randomized phase II trial

Fluorouracil, leucovorin and oxaliplatin (FLO) versus fluorouracil, leucovorin and cisplatin (FLP) as a first line therapy for patients with advanced gastric cancer; first interim analysis of a randomised multicenter phase II study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4015 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4015-4015 ◽

Cited By ~ 7

Author(s):

S.-E. Al-Batran ◽

J. Stöhlmacher ◽

S. Probst ◽

S. Hollerbach ◽

G. Wilhelm ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Interim Analysis ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽

Multicenter Phase ◽

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of Oncology ◽

10.1093/annonc/mdm269 ◽

2007 ◽

Vol 18 (10) ◽

pp. 1673-1679 ◽

Cited By ~ 98

Author(s):

S. Lorenzen ◽

M. Hentrich ◽

C. Haberl ◽

V. Heinemann ◽

T. Schuster ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Gastroesophageal Junction ◽

First Line ◽

Split Dose ◽

First Line Therapy ◽

Pazopanib with 5‐FU and oxaliplatin as first line therapy in advanced gastric cancer: a randomized phase‐II study ‐ the PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO‐STO ‐0510

International Journal of Cancer ◽

10.1002/ijc.33864 ◽

2021 ◽

Author(s):

Anica Högner ◽

Salah‐Eddin Al‐Batran ◽

Jens T. Siveke ◽

Mario Lorenz ◽

Prisca Bartels ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Safety analysis of weekly paclitaxel plus S-1 versus paclitaxel plus 5-fluorouracil/calcium folinate as first-line therapy in advanced gastric cancer: a multicenter open random phase II trial

Journal of Chemotherapy ◽

10.1179/1973947812y.0000000057 ◽

2013 ◽

Vol 25 (1) ◽

pp. 56-59

Author(s):

Ting Deng ◽

Nong Xu ◽

Jian-Ping Xiong ◽

Zhao Yan ◽

Zhi-Xiang Zhuang ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Random Phase ◽

Calcium Folinate ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2334-3 ◽

2013 ◽

Vol 73 (1) ◽

pp. 163-169 ◽

Cited By ~ 15

Author(s):

Young Saing Kim ◽

Sun Jin Sym ◽

Se Hoon Park ◽

Inkeun Park ◽

Junshik Hong ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

First Line ◽

Weekly Docetaxel ◽

First Line Therapy ◽

Line Therapy ◽

Randomized phase II trial of weekly paclitaxel + ramucirumab versus weekly nab-paclitaxel + ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy: WJOG10617G/P-SELECT

Annals of Oncology ◽

10.1093/annonc/mdz247.164 ◽

2019 ◽

Vol 30 ◽

pp. v323

Author(s):

K. Hirata ◽

Y. Hamamoto ◽

K. Tsuchihashi ◽

C. Kondoh ◽

K. Yamazaki ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Peritoneal Dissemination ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Recurrent Gastric Cancer ◽

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.2247 ◽

2020 ◽

Vol 31 ◽

pp. S1151

Author(s):

J. Albanell ◽

M.T.M. Martinez ◽

M. Ramos ◽

M.O.' Connor ◽

L. De la Cruz-Merino ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

A phase II study of paclitaxel and capecitabine combination chemotherapy in patients with advanced gastric cancer as a first-line therapy

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4051 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4051-4051 ◽

Cited By ~ 5

Author(s):

H. J. Kang ◽

T. W. Kim ◽

H. M. Chang ◽

M.-H. Ryu ◽

J. H. Yook ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Study ◽

First Line ◽

First Line Therapy ◽

A randomized phase II trial of docetaxel plus S-1 versus docetaxel plus cisplatin in advanced gastric cancer as a first-line treatment

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.4534 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 4534-4534 ◽

Cited By ~ 2

Author(s):

H. Jeung ◽

C. Im ◽

S. Rha ◽

J. Ahn ◽

S. Shin ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Line Treatment ◽

First Line ◽

Randomized Phase Ii ◽

First Line Treatment